A dual-enzyme cleavable linker for antibody-drug conjugates

被引：23

作者：

Bargh, Jonathan D. ^{[1
]}

Walsh, Stephen J. ^{[1
,2
]}

Ashman, Nicola ^{[1
]}

Isidro-Llobet, Albert ^{[3
]}

Carroll, Jason S. ^{[2
]}

Spring, David R. ^{[1
]}

机构：

[1] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England

[2] Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England

[3] GSK, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England

来源：

CHEMICAL COMMUNICATIONS | 2021年 / 57卷 / 28期

基金：

英国工程与自然科学研究理事会;

关键词：

Enzymes;

D O I：

10.1039/d1cc00957e

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

A novel enzyme cleavable linker for antibody-drug conjugates is reported. The 3-O-sulfo-beta-galactose linker is cleaved sequentially by two lysosomal enzymes - arylsulfatase A and beta-galactosidase - to release the payload in targeted cells. An alpha-HER2 antibody-drug conjugate synthesised using this highly hydrophilic dual-cleavable linker exhibited excellent cytotoxicity and selectivity.

引用

页码：3457 / 3460

页数：4

共 27 条

[1] Sulfatase-cleavable linkers for antibody-drug conjugates [J].

Bargh, Jonathan D. ;

Walsh, Stephen J. ;

Isidro-Llobet, Albert ;

Omarjee, Soleilmane ;

Carroll, Jason S. ;

Spring, David R. .

CHEMICAL SCIENCE, 2020, 11 (09) :2375-2380

[2] Cleavable linkers in antibody-drug conjugates [J].

Bargh, Jonathan D. ;

Isidro-Llobet, Albert ;

Parker, Jeremy S. ;

Spring, David R. .

CHEMICAL SOCIETY REVIEWS, 2019, 48 (16) :4361-4374

[3] Strategies and challenges for the next generation of antibody drug conjugates [J].

Beck, Alain ;

Goetsch, Liliane ;

Dumontet, Charles ;

Corvaia, Nathalie .

NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (05) :315-337

[4] Design, Synthesis, and Biological Evaluation of Antibody-Drug Conjugates Comprised of Potent Camptothecin Analogues [J].

Burke, Patrick J. ;

Senter, Peter D. ;

Meyer, David W. ;

Miyamoto, Jamie B. ;

Anderson, Martha ;

Toki, Brian E. ;

Manikumar, Govindarajan ;

Wani, Mansukh C. ;

Kroll, David J. ;

Jeffrey, Scott C. .

BIOCONJUGATE CHEMISTRY, 2009, 20 (06) :1242-1250

[5] Expeditious Total Synthesis of Hemiasterlin through a Convergent Multicomponent Strategy and Its Use in Targeted Cancer Therapeutics [J].

Charoenpattarapreeda, Jiraborrirak ;

Walsh, Stephen J. ;

Carroll, Jason S. ;

Spring, David R. .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, 59 (51) :23045-23050

[6]

Chudasama Vijay, 2018, Drug Discov Today Technol, V30, P1, DOI 10.1016/j.ddtec.2018.11.003

[7] Development of potent monoclonal antibody auristatin conjugates for cancer therapy [J].

Doronina, SO ;

Toki, BE ;

Torgov, MY ;

Mendelsohn, BA ;

Cerveny, CG ;

Chace, DF ;

DeBlanc, RL ;

Gearing, RP ;

Bovee, TD ;

Siegall, CB ;

Francisco, JA ;

Wahl, AF ;

Meyer, DL ;

Senter, PD .

NATURE BIOTECHNOLOGY, 2003, 21 (07) :778-784

[8] Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design [J].

Dorywalska, Magdalena ;

Dushin, Russell ;

Moine, Ludivine ;

Farias, Santiago E. ;

Zhou, Dahui ;

Navaratnam, Thayalan ;

Lui, Victor ;

Hasa-Moreno, Adela ;

Casas, Meritxell Galindo ;

Tran, Thomas-Toan ;

Delaria, Kathy ;

Liu, Shu-Hui ;

Foletti, Davide ;

O'Donnell, Christopher J. ;

Pons, Jaume ;

Shelton, David L. ;

Rajpal, Arvind ;

Strop, Pavel .

MOLECULAR CANCER THERAPEUTICS, 2016, 15 (05) :958-970

[9] Advances in Antibody-Drug Conjugate Design: Current Clinical Landscape and Future Innovations [J].

Gauzy-Lazo, Laurence ;

Sassoon, Ingrid ;

Brun, Marie-Priscille .

SLAS DISCOVERY, 2020, 25 (08) :843-868

[10] DIBUTYLSTANNYLENE ACETALS - USEFUL INTERMEDIATES FOR THE REGIOSELECTIVE SULFATION OF GLYCOSIDES [J].

GUILBERT, B ;

DAVIS, NJ ;

PEARCE, M ;

APLIN, RT ;

FLITSCH, SL .

TETRAHEDRON-ASYMMETRY, 1994, 5 (11) :2163-2178

← 1 2 3 →